Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients

• Главные авторы: Marcos Alejandro Mayer (Автор), Alejandro Krolewiecki (Автор), Alejandro Ferrero (Автор), Marcelo Bocchio (Автор), Juan Barbero (Автор), Marcos Miguel (Автор), Ariel Paladini (Автор), Carlos Delgado (Автор), Juan Ramón Ojeda (Автор), Claudia Elorza (Автор), Ana Bertone (Автор), Pedro Emanuel Fleitas (Автор), Gustavo Vera (Автор), Mario Rubén Kohan (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

BackgroundIn the absence of antiviral alternatives, interventions under research for COVID-19 might be offered following guidelines from WHO for monitored emergency use of unregistered and experimental interventions (MEURI). Ivermectin is among several drugs explored for its role against SARS-CoV-2,...